{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:50:40Z","timestamp":1779256240986,"version":"3.51.4"},"posted":{"date-parts":[[2023,11,8]]},"group-title":"Hematology","reference-count":45,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,11,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>PURPOSE<\/jats:title>\n                  <jats:p>Gamma delta T-cell receptor-positive acute lymphoblastic leukemia (\u03b3\u03b4 T-ALL) is a high-risk but poorly characterized disease.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We studied clinical features of 200 pediatric \u03b3\u03b4 T-ALL, and compared the prognosis of 93 cases to 1,067 protocol-matched non-\u03b3\u03b4 T-ALL. Genomic features were defined by transcriptome and genome sequencing. Experimental modeling was used to examine the mechanistic impacts of genomic alterations. Therapeutic vulnerabilities were identified by high throughput drug screening of cell lines and xenografts.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>\n                    \u03b3\u03b4 T-ALL in children under three was extremely high-risk with 5-year event-free survival (33% v. 70% [age 3-&lt;10] and 73% [age \u226510],\n                    <jats:italic>P<\/jats:italic>\n                    =9.5 x 10\n                    <jats:sup>-5<\/jats:sup>\n                    ) and 5-year overall survival (49% v. 78% [age 3-&lt;10] and 81% [age \u226510],\n                    <jats:italic>P<\/jats:italic>\n                    =0.002), differences not observed in non-\u03b3\u03b4 T-ALL. \u03b3\u03b4 T-ALL in this age group was enriched for genomic alterations activating\n                    <jats:italic>LMO2<\/jats:italic>\n                    activation and inactivating\n                    <jats:italic>STAG2<\/jats:italic>\n                    inactivation (\n                    <jats:italic>STAG2\/LMO2<\/jats:italic>\n                    ). Mechanistically, we show that inactivation of STAG2 profoundly perturbs chromatin organization by altering enhancer-promoter looping resulting in deregulation of gene expression associated with T-cell differentiation. Drug screening showed resistance to prednisolone, consistent with clinical slow treatment response, but identified a vulnerability in DNA repair pathways arising from STAG2 inactivation, which was efficaciously targeted by Poly(ADP-ribose) polymerase (PARP) inhibition, with synergism with HDAC inhibitors. Ex-vivo drug screening on PDX cells validated the efficacy of PARP inhibitors as well as other potential targets including nelarabine.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>CONCLUSION<\/jats:title>\n                  <jats:p>\n                    \u03b3\u03b4 T-ALL in children under the age of three is extremely high-risk and enriched for\n                    <jats:italic>STAG2\/LMO2<\/jats:italic>\n                    ALL. STAG2 loss perturbs chromatin conformation and differentiation, and\n                    <jats:italic>STAG2\/LMO2<\/jats:italic>\n                    ALL is sensitive to PARP inhibition. These data provide a diagnostic and therapeutic framework for pediatric \u03b3\u03b4 T-ALL.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>SUPPORT<\/jats:title>\n                  <jats:p>The authors are supported by the American and Lebanese Syrian Associated Charities of St Jude Children\u2019s Research Hospital, NCI grants R35 CA197695, P50 CA021765 (C.G.M.), the Henry Schueler 41&amp;9 Foundation (C.G.M.), and a St. Baldrick\u2019s Foundation Robert J. Arceci Innovation Award (C.G.M.), Gabriella Miller Kids First X01HD100702 (D.T.T and C.G.M.) and R03CA256550 (D.T.T. and C.G.M.), F32 5F32CA254140 (L.M.), and a Garwood Postdoctoral Fellowship of the Hematological Malignancies Program of the St Jude Children\u2019s Research Hospital Comprehensive Cancer Center (S.K.). This project was supported by the National Cancer Institute of the National Institutes of Health under the following award numbers: U10CA180820, UG1CA189859, U24CA114766, U10CA180899, U10CA180866 and U24CA196173.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCLAIMER<\/jats:title>\n                  <jats:p>The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agencies were not directly involved in the design of the study, gathering, analysis and interpretation of the data, writing of the manuscript, or decision to submit the manuscript for publication.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.11.06.23298028","type":"posted-content","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T14:10:27Z","timestamp":1699452627000},"source":"Crossref","is-referenced-by-count":2,"title":["Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2\/LMO2 \u03b3\u03b4 T-ALL as an extremely high risk leukemia in the very young"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-467X","authenticated-orcid":false,"given":"Shunsuke","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri","family":"Polonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Shik","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Iacobucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen EJ","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Buldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"3rd","given":"Burgess B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsey","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiew","family":"Kean Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Varotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M","family":"Paietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Elisa Muhle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Vibeke","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester A.","family":"de Groot-Kruseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Kim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jules P.P.","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Pawinska-Wasikowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine R.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mellissa","family":"Maybury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Svaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Reiterova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kicinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mollie S.","family":"Prater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Mazilier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi S","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Elitzur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina M.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharnise","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shondra M.","family":"Pruett-Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"K\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Kornblau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szymon","family":"Skocze\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffaney L","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Conter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunchao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongshan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Yinmei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0605-7342","authenticated-orcid":false,"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023111103200667000_2023.11.06.23298028v1.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.7250"},{"key":"2023111103200667000_2023.11.06.23298028v1.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00256"},{"key":"2023111103200667000_2023.11.06.23298028v1.3","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2352-3026(23)00072-8","article-title":"Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"2023111103200667000_2023.11.06.23298028v1.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-338707"},{"key":"2023111103200667000_2023.11.06.23298028v1.5","doi-asserted-by":"crossref","unstructured":"Pui CH , Pei D , Cheng C , et al: Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor. Oncoimmunology 8:1599637, 2019","DOI":"10.1080\/2162402X.2019.1599637"},{"key":"2023111103200667000_2023.11.06.23298028v1.6","first-page":"264","article-title":"Gammadelta and alphabeta T-cell acute lymphoblastic leukemia: comparison of their clinical and immunophenotypic features","volume":"90","year":"2005","journal-title":"Haematologica"},{"key":"2023111103200667000_2023.11.06.23298028v1.7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/hematology.2022000338","article-title":"Ph+ ALL in 2022: is there an optimal approach?","volume":"2022","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2023111103200667000_2023.11.06.23298028v1.8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.247031"},{"key":"2023111103200667000_2023.11.06.23298028v1.9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","year":"2019","journal-title":"Blood"},{"key":"2023111103200667000_2023.11.06.23298028v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3909"},{"key":"2023111103200667000_2023.11.06.23298028v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3900"},{"key":"2023111103200667000_2023.11.06.23298028v1.12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0145"},{"key":"2023111103200667000_2023.11.06.23298028v1.13","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","year":"2022","journal-title":"Blood"},{"key":"2023111103200667000_2023.11.06.23298028v1.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.6364"},{"key":"2023111103200667000_2023.11.06.23298028v1.15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hon.2791","article-title":"Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia","volume":"38","year":"2020","journal-title":"Hematol Oncol"},{"key":"2023111103200667000_2023.11.06.23298028v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900386"},{"key":"2023111103200667000_2023.11.06.23298028v1.17","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16","volume":"37","year":"2019","journal-title":"J Clin Oncol"},{"key":"2023111103200667000_2023.11.06.23298028v1.18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood.2021012328","article-title":"Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium","volume":"139","year":"2022","journal-title":"Blood"},{"key":"2023111103200667000_2023.11.06.23298028v1.19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2022-167157","article-title":"Comprehensive Genome Characterization of Childhood T-ALL Links Oncogene Activation Mechanism and Subtypes to Prognosis","volume":"140","year":"2022","journal-title":"Blood"},{"key":"2023111103200667000_2023.11.06.23298028v1.20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1216557"},{"key":"2023111103200667000_2023.11.06.23298028v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2020.02.024"},{"key":"2023111103200667000_2023.11.06.23298028v1.22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ccell.2021.05.007","article-title":"STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma","volume":"39","year":"2021","journal-title":"Cancer Cell"},{"key":"2023111103200667000_2023.11.06.23298028v1.23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccell.2021.04.001","article-title":"STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma","volume":"39","year":"2021","journal-title":"Cancer Cell"},{"key":"2023111103200667000_2023.11.06.23298028v1.24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2019.08.003","article-title":"Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation","volume":"25","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2023111103200667000_2023.11.06.23298028v1.25","doi-asserted-by":"crossref","unstructured":"Tothova Z , Valton AL , Gorelov RA , et al: Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS\/AML. JCI Insight 6, 2021","DOI":"10.1172\/jci.insight.142149"},{"key":"2023111103200667000_2023.11.06.23298028v1.26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0749"},{"key":"2023111103200667000_2023.11.06.23298028v1.27","doi-asserted-by":"crossref","unstructured":"Padella A , Ghelli Luserna Di Rora A , Marconi G , et al: Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. J Hematol Oncol 15:10, 2022","DOI":"10.1186\/s13045-022-01228-0"},{"key":"2023111103200667000_2023.11.06.23298028v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09659-z"},{"key":"2023111103200667000_2023.11.06.23298028v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.03.007"},{"key":"2023111103200667000_2023.11.06.23298028v1.30","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1182\/bloodadvances.2020002049","article-title":"The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1","volume":"4","year":"2020","journal-title":"Blood Adv"},{"key":"2023111103200667000_2023.11.06.23298028v1.31","first-page":"e4731","article-title":"Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells","volume":"13","year":"2023","journal-title":"Bio Protoc"},{"key":"2023111103200667000_2023.11.06.23298028v1.32","doi-asserted-by":"crossref","unstructured":"Tieppo P , Papadopoulou M , Gatti D , et al: The human fetal thymus generates invariant effector gammadelta T cells. J Exp Med 217, 2020","DOI":"10.1084\/jem.20190580"},{"key":"2023111103200667000_2023.11.06.23298028v1.33","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1111\/febs.16045","article-title":"Developing the right tools for the job: Lin28 regulation of early life T-cell development and function","volume":"289","year":"2022","journal-title":"FEBS J"},{"key":"2023111103200667000_2023.11.06.23298028v1.34","doi-asserted-by":"crossref","unstructured":"Abdulla HD , Alserihi R , Flensburg C , et al: Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition. J Exp Med 220, 2023","DOI":"10.1084\/jem.20212383"},{"key":"2023111103200667000_2023.11.06.23298028v1.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-692582"},{"key":"2023111103200667000_2023.11.06.23298028v1.36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1182378"},{"key":"2023111103200667000_2023.11.06.23298028v1.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz3418"},{"key":"2023111103200667000_2023.11.06.23298028v1.38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41568-020-0270-1","article-title":"Emerging themes in cohesin cancer biology","volume":"20","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2023111103200667000_2023.11.06.23298028v1.39","doi-asserted-by":"publisher","DOI":"10.1101\/gr.253211.119"},{"key":"2023111103200667000_2023.11.06.23298028v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-018-0070-4"},{"key":"2023111103200667000_2023.11.06.23298028v1.41","doi-asserted-by":"crossref","unstructured":"Smith JS , Lappin KM , Craig SG , et al: Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML. J Transl Med 18:339, 2020","DOI":"10.1186\/s12967-020-02500-y"},{"key":"2023111103200667000_2023.11.06.23298028v1.42","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-022-29541-9","article-title":"STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming","volume":"13","year":"2022","journal-title":"Nat Commun"},{"key":"2023111103200667000_2023.11.06.23298028v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.002"},{"key":"2023111103200667000_2023.11.06.23298028v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"2023111103200667000_2023.11.06.23298028v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.11.06.23298028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:44:33Z","timestamp":1768506273000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.11.06.23298028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1101\/2023.11.06.23298028","relation":{},"subject":[],"published":{"date-parts":[[2023,11,8]]},"subtype":"preprint"}}